Practical Strategies for Parenting ADHD

Wish you could just roll with the ADHD in your family?

Need practical strategies to deal with the day to day parenting of a child with ADHD? Sign up today for this FREE learning series from BC Children's Hospital.

“I can’t thank you enough for this. I have not found many resources as practical as this. I can

honestly say that I am sad to complete the videos because I have found the information so
helpful and I feel such a sense of support by watching them.”
– Rolling with ADHD Participant

What is Rolling with ADHD?

Play Video

Raising a child is one of the hardest jobs out there. Parenting a child with ADHD is even tougher. We often tell parents that they need a ‘black belt’ in parenting when they have a child with ADHD. That is why we decided to bring together psychologists from the ADHD Clinic at BC Children’s Hospital and caregivers to provide you with support.

Rolling with ADHD is an eight module series that covers practical tools and strategies for caregivers of children with ADHD. This series has been adapted from the long standing in-person program at BC Children’s Hospital, and  includes what research show really works for kids and families living with ADHD.

“I really enjoyed the module format. It was visually easy to follow.
It was great to gain insight into my child’s behaviors and to know what is normal for children with ADHD.
This has helped improve our relationship with our child. We are much more positive.
Thank you very much for this helpful resource!

– Rolling with ADHD Participant

This series is for you if:

“This is an amazing resource, and I have already recommended it to many parents.
I wish I had found it sooner.

– Rolling with ADHD Participant

How It Works

Sign up for the course! Click the ‘Register’ button below to register for the course. You will receive access to the full eight-module course.

Short and impactful content – we know you’re busy!  Each module includes 15-20 minute video with activities to help you remember the key information and to think about how to apply the strategies to your family.

Focus on real life – You’ll be invited to reflect on how you have been approaching different issues with your children and how to start making adjustments.

Absolute Privacy – You’ll have a safe, secure space to interact as little or as much as you want with the course material.

Our unique learning system allows you to create notes, make reflections and journal your progress in total privacy. The program also provides you with downloadable resources and a window into how other parents are approaching the everyday issues you face. You are not alone!

“Thank you for a concise, practical and credible course.
There is so much information out there – credible and not – that it can be overwhelming, so I was quite grateful for this.

– Rolling with ADHD Participant

Your Guides:

Dr. Candice Murray,
Registered Psychologist

Dr. Candice Murray is a registered psychologist who practices in the area of ADHD. She is the former Director of the Provincial ADHD Program at BC Children’s Hospital and is a Clinical Instructor in the Department of Psychiatry at the University of British Columbia. …read more

Dr. Daphné Dokis
Registered Psychologist

Dr. Daphné Dokis is a Registered Psychologist who works with children, adolescents and their families In the ADHD Clinic and in her private practice. Over the past 10 years, Dr. Dokis has developed expertise supporting families with ADHD and other challenging behaviours. …read more

Thank You!

Made possible by the generosity of the Lu Family

Rolling with ADHD logo

SGAs would be indicated as a first line therapy for Schizophrenia and for the positive symptoms of psychotic disorders in general. SGAs treat active psychosis as well as decrease relapses if remission from active symptoms is achieved.

SGAs would not be prescribed for depression unless a psychotic depression was present. For a depression without psychotic symptoms, first line treatment would be an SSRI antidepressant. The potential side effects of SGAs and lack of clinical evidence supporting efficacy of SGAs in depression without psychotics symptoms are both reasons SGAs would not be prescribed for this condition.

Bipolar Mood D/O:
SGAs are often prescribed for Bipolar Disorder. They stabilize mood as well as treat psychotic symptoms associated with mania. Often they are used in combination with mood stabilizers especially to stabilize mania in its initial phase as the mood stabilizers are titrated up. SGAs can be used alone or in combination with mood stabilizers to treat bipolar disorder.

Tourette Syndrome
SGAs would not be prescribed for the treatment of Tourette syndrome. Guidelines for Tourette’s note that antipsychotics may be prescribed only when the potential benefits of treatment outweigh the risks, ie if the symptoms are significantly functionally impairing. For tics, if medication required, alpha adrenergic agonists are “strongly” recommended with clonidine associated with more reduction than guanfacine XR. For tics and Tourette’s, there is a “weak” recommendation made for FGAs and SGAs, and other treatments.

SGAs would not be prescribed to treat ADHD. They are sometimes used in conjunction with expert consultation for off-label, preferably third line use, for short-term treatment for significant irritability and explosive emotions/behaviours while stabilizing on first line and/or second line treatment. First line treatment for ADHD includes monotherapy with long acting stimulants; second line treatment includes combination of first line treatments with guanfacine XR, or atomoxetine, or short-acting stimulants. Third line treatments include NDRIs (bupropion) and clonidine (monotherapy or in combination with stimulants). Comorbidities should be treated with first line treatments specific to the individual condition.

Eating Disorders (AN, BN, ARFID)
SGAs are, in children and adolescents, primarily prescribed for symptom management in severe eating disorders. There are mixed results for enduring effects on weight restoration and any potential benefits are balanced with the well-established risks. For treatment of anorexia nervosa, there are limited positive studies with the use of olanzapine, with quetiapine and aripiprazole having even fewer studies with mild benefit noted at times. Risperidone does not have evidence for AN. ARFID has limited positive reports for olanzapine. Use of SSRIs, specifically fluoxetine, has the most evidence for bulimia nervosa, in which high doses are demonstrated to reduce purging behaviour. There are risks for increased binging with SGAs in BN. SGAs are used off label to help with emotional and behavioral regulation, with some benefit at times for depression and anxiety symptoms, but experts should be consulted prior to initiating. Comorbidities should be treated with first line agents (NOTE: Wellbutrin is contraindicated in eating disorders secondary to seizure risk).